Obstructive sleep apnoea and increased inflammatory activity in non-obese patients with coronary artery disease in the RICCADSA trial

Y. Peker, E. Thunström, H. Glantz, M. Fu, T. Yücel-Lindberg, M. Petzold, K. Lindberg (Gothenburg, Skövde, Stockholm, Sweden)

Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Session: Burn after reading: inflammation in sleep disordered breathing
Session type: Oral Presentation
Number: 5030
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Peker, E. Thunström, H. Glantz, M. Fu, T. Yücel-Lindberg, M. Petzold, K. Lindberg (Gothenburg, Skövde, Stockholm, Sweden). Obstructive sleep apnoea and increased inflammatory activity in non-obese patients with coronary artery disease in the RICCADSA trial. Eur Respir J 2013; 42: Suppl. 57, 5030

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Prevalence and severity of obstructive sleep apnea syndrome in patients with atherosclerosis: A study using carotid ultrasonography and coronary angiography
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Effect of obstructive sleep apnea in severity and short-term prognosis of acute coronary syndrome
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015


Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016



8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016


Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Obstructive sleep apnoea and nocturnal arrhythmias in patients with ischaemic heart disease
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015


Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Alteration of inflammatory mediators in patients with obstructive sleep apnea
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017

The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016